Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

418 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis.
Saiz A, Marcos MA, Graus F, Vidal J, Jimenez de Anta MT. Saiz A, et al. J Neurol. 2001 Jul;248(7):617-8. doi: 10.1007/s004150170141. J Neurol. 2001. PMID: 11518005 No abstract available.
Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study.
Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, Tolosa E, Rozman C. Graus F, et al. Among authors: saiz a. Neurology. 1996 Apr;46(4):1004-9. doi: 10.1212/wnl.46.4.1004. Neurology. 1996. PMID: 8780080
14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis.
Martínez-Yélamos A, Saiz A, Sanchez-Valle R, Casado V, Ramón JM, Graus F, Arbizu T. Martínez-Yélamos A, et al. Among authors: saiz a. Neurology. 2001 Aug 28;57(4):722-4. doi: 10.1212/wnl.57.4.722. Neurology. 2001. PMID: 11524491
A positive 14-3-3 assay was the only independent predictor for a shorter time to conversion to clinical definite MS (risk ratio 4.1; 95% CI 1.1 to 15) and to reach an Expanded Disability Status Scale (EDSS) > or =2 at the end of follow-up (odds ratio 14.8; 95% CI
A positive 14-3-3 assay was the only independent predictor for a shorter time to conversion to clinical definite MS (risk rati
No association of inducible nitric oxide synthase gene ( NOS2A) to multiple sclerosis.
Blanco Y, Yagüe J, Graus F, Saiz A. Blanco Y, et al. Among authors: saiz a. J Neurol. 2003 May;250(5):598-600. doi: 10.1007/s00415-003-1047-7. J Neurol. 2003. PMID: 12736741
Nitric oxide (NO) is a nonspecific inflammatory mediator that has been involved in the pathogenesis of multiple sclerosis (MS). ...
Nitric oxide (NO) is a nonspecific inflammatory mediator that has been involved in the pathogenesis of multiple sclerosis (MS). ...
Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS.
Saiz A, Blanco Y, Carreras E, Berenguer J, Rovira M, Pujol T, Marín P, Arbizu T, Graus F. Saiz A, et al. Neurology. 2004 Jan 27;62(2):282-4. doi: 10.1212/wnl.62.2.282. Neurology. 2004. PMID: 14745069
The authors report the outcome of 14 patients with severe multiple sclerosis treated with autologous hematopoietic stem cell transplantation (AHSCT) after a median follow-up period of 3 years. ...
The authors report the outcome of 14 patients with severe multiple sclerosis treated with autologous hematopoietic stem cell transplantation …
CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS.
Martínez-Yélamos A, Rovira A, Sánchez-Valle R, Martínez-Yélamos S, Tintoré M, Blanco Y, Graus F, Montalban X, Arbizu T, Saiz A. Martínez-Yélamos A, et al. Among authors: saiz a. J Neurol. 2004 Oct;251(10):1278-9. doi: 10.1007/s00415-004-0524-y. J Neurol. 2004. PMID: 15503113 No abstract available.
Autologous haematopoietic-stem-cell transplantation for multiple sclerosis.
Blanco Y, Saiz A, Carreras E, Graus F. Blanco Y, et al. Among authors: saiz a. Lancet Neurol. 2005 Jan;4(1):54-63. doi: 10.1016/S1474-4422(04)00966-4. Lancet Neurol. 2005. PMID: 15620857 Review.
Intense immunosuppression followed by autologous haematopoietic-stem-cell transplantation (HSCT) is being assessed as a potential treatment for patients with severe multiple sclerosis (MS). ...Autologous HSCT seems feasible in MS and assessment with clinical and MRI measur …
Intense immunosuppression followed by autologous haematopoietic-stem-cell transplantation (HSCT) is being assessed as a potential tre …
Neurological complications of hematopoietic cell transplantation.
Saiz A, Graus F. Saiz A, et al. Semin Neurol. 2004 Dec;24(4):427-34. doi: 10.1055/s-2004-861537. Semin Neurol. 2004. PMID: 15637654 Review.
Hematopoietic cell transplantation (HCT) involves the intravenous infusion of hematopoietic progenitor cells from the patient (autologous) or a human leukocyte antigen-matched donor (allogeneic). Before transplantation, the recipient undergoes a conditioning regimen …
Hematopoietic cell transplantation (HCT) involves the intravenous infusion of hematopoietic progenitor cells from the patient (autologous) o …
Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies.
Hernández-Echebarría L, Saiz A, Arés A, Tejada J, García-Tuñón L, Nieves C, Graus F. Hernández-Echebarría L, et al. Among authors: saiz a. Neurology. 2006 Feb 14;66(3):450-1. doi: 10.1212/01.wnl.0000196488.87746.7b. Neurology. 2006. PMID: 16476955 No abstract available.
Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
Llufriu S, Castillo J, Blanco Y, Ramió-Torrentà L, Río J, Vallès M, Lozano M, Castellà MD, Calabia J, Horga A, Graus F, Montalban X, Saiz A. Llufriu S, et al. Among authors: saiz a. Neurology. 2009 Sep 22;73(12):949-53. doi: 10.1212/WNL.0b013e3181b879be. Neurology. 2009. PMID: 19770470
418 results
Jump to page
Feedback